Richard Simmons would like everyone to know how he feels about Melissa McCarthy. After Barbra Streisand made headlines with her Instagram question about the Bridesmaids star using Ozempic ...

While Ozempic use is hardly a secret, fans were left shocked after iconic singer and actress Barbra Streisand left a comment on one of Melissa McCarthy’s Instagram posts straight up asking her ...

The celebrated actress has lost more than 100Ib after turning to controversial diabetes jab Ozempic - now better known for its impact on tackling obesity ...

Barbra Streisand may have been verging on rude last year when she wrote on actor Melissa McCarthy’s Instagram: “Did you take Ozempic?” There was a global gasp as observers wondered how the ...

But long before Mounjaro and Ozempic were a thing ... While talking with People in 2011, actress Melissa McCarthy, now 54, recalled an all-liquid diet a doctor put her on in 2003 when she ...

Melissa McCarthy predicted her aunt and uncle would 'scream, then cry' after seeing their secretly renovated Chicago home on Monday's episode of Celebrity IOU. The 49-year-old actress was right ...

New cast updates also reveal milestones like Milo Ventimiglia’s secret wedding and baby news, Melissa McCarthy’s thriving career and Jared Padalecki’s continued TV success post-Supernatural.

The 2015 action-comedy film starred Statham along with Melissa McCarthy, Jude Law, Rose Byrne and Miranda Hart in key roles. While Feig is willing to make a new entry for his hit film, he also has ...

Lizzo broke down exactly how she lost 16 percent of her body fat after denying rumors she used medications like Ozempic or Mounjaro ... Lizzo — whose real name is Melissa Jefferson — recalled ...

Carnie Wilson will not be turning to Ozempic for weight loss anytime soon. During an interview with Fox News Digital, Wilson, who previously lost more than 100 pounds with gastric bypass and lap ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.